Patients with cirrhosis have increased sensitivity to drugs, and can choose antifibrotic drugs, enzyme-lowering and anti-yellowing drugs, vitamin drugs, metabolism-promoting drugs, liver-protecting and repairing drugs, nutritional supportive drugs, and metabolism-promoting drugs, according to the patient's specific situation. Patients with advanced cirrhosis have malfunctioning liver metabolism, and can take drugs to promote metabolism, which theoretically can supply the body's energy needs, such as adenosine triphosphate, coenzyme A and so on. Vitamin drugs have a protective effect on the liver, can participate in the body's metabolism, maintain cell function, commonly used yeast tablets and vitamin B complex preparations. Enzyme-lowering and jaundice-reducing drugs: potentin, potassium magnesium menthonate, danshen injection, simethicone and other drugs have the effect of lowering transaminases in cirrhotic patients and promoting the subsidence of jaundice. Nutritional support drugs: human blood albumin, fresh blood plasma, fat milk, energy combination and other drugs, with better liver protection, supplemental nutrition. Anti-fibrotic drugs, liver fibrosis is the pathological process of liver disease developing into cirrhosis, colchicine, interferon, penicillamine and so on have anti-fibrotic effect. Hepatoprotective and restorative drugs: silymarin and inosine are commonly used hepatoprotective and restorative drugs, silymarin has the effect of protecting liver cell membranes and fighting against a variety of liver toxins, and inosine is able to promote the recovery of damaged liver cells. At present, there are many varieties of hepatoprotective drugs on the market, if the liver function is normal, generally should not take hepatoprotective drugs, if the liver function is abnormal, you can choose 1-2 kinds of hepatoprotective, enzyme-lowering, yellow-lowering drug treatment, patients in taking these drugs, it is best to use under the guidance of the doctor reasonably, must not be cloudy, blindly use the drug. Liver fibrosis is the pathological basis of cirrhosis, early cirrhosis often has active liver fiber proliferation, the relevant indicators significantly higher, therefore, anti-fibrotic treatment is important for preventing the development of early cirrhosis, the principle of medication is to target the cause of the disease, the rational use of drugs.